Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications acetaminophen use pregnancy neurodevelopment attention function autism spectrum
… approval, clearance, or licensure of the product or new use Product pricing information Patient utilization … effectiveness of the unapproved product or the unapproved use) In addition to the above information, the guidance … from Phase 1, Phase 2, and Phase 3 studies (peer-reviewed publications; congress abstracts, posters, and presentations; …
… some of the impacts of COVID-19 on the collection and use of clinical outcome assessment (COA) data. They drew …
Benefit-Risk Preferences Benefit-risk preference studies are a specific application of stated-preference methods and are used to determine how your patients and other decision-makers perceive the benefits of your treatment features and their tolerance for …
Psychometric Evaluation Our psychometricians have extensive experience conducting quantitative evaluations of COAs, evaluating their structure and demonstrating their reliability, validity, and responsiveness, as well as facilitating the interpretation of …
… research experience in the field of asthma and drug use during pregnancy, including studies performed within the Danish …
… as mixing and matching vaccines, boosters, and vaccine use in children are fundamentally changing that landscape. …
Differences and Similarities of Health Economic Evaluation for Medical Technologies by HTA Bodies Vijay D'Souza, PhD Senior Associate, Market Access and Outcomes Strategy Transcript In recent years, an increasing number of medical technologies such as …
… we may collect or acquire about you, how we may use it, when we may disclose the information, and the steps … data that provides your precise location. 3 HOW WE USE AND COLLECT YOUR PERSONAL INFORMATION IN RESEARCH When … such period as is appropriate for its intended and lawful use. Any Personal Data that is collected by RTI-HS or …
Celebrating 20 Years of Research Share on: September 30, 2020 On October 1, 2000, RTI Health Solutions was officially launched under the leadership of Jo Mauskopf. Twenty years later, we're excited to have reached this milestone in our journey of …
… acute coronary syndromes, acute myeloid leukemia, attention-deficit/hyperactivity disorder, chronic obstructive …